109 results on '"Burchell, Ann N."'
Search Results
2. A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in Canada.
- Author
-
Benoit AC, Younger J, Beaver K, Jackson R, Loutfy M, Masching R, Nobis T, Nowgesic E, O'Brien-Teengs D, Whitebird W, Zoccole A, Hull M, Jaworsky D, Rachlis A, Rourke S, Burchell AN, Cooper C, Hogg R, Klein MB, Machouf N, Montaner J, Tsoukas C, and Raboud J
- Subjects
- Adult, Antiretroviral Therapy, Highly Active, Black People, CD4 Lymphocyte Count, Canada, Cohort Studies, Female, HIV growth & development, HIV Infections virology, Homosexuality, Male, Humans, Male, Middle Aged, Population Groups, Recurrence, Substance Abuse, Intravenous, Treatment Outcome, White People, Anti-HIV Agents therapeutic use, HIV drug effects, HIV Infections drug therapy, HIV Infections ethnology, Viral Load drug effects
- Abstract
Background: This study compared time to virological suppression and rebound between Indigenous and non-Indigenous individuals living with HIV in Canada initiating combination antiretroviral therapy (cART)., Methods: Data were from the Canadian Observational Cohort collaboration; eight studies of treatment-naive persons with HIV initiating cART after 1/1/2000. Fine and Gray models were used to estimate the effect of ethnicity on time to virological suppression (two consecutive viral loads [VLs] <50 copies/ml at least 3 months apart) after adjusting for the competing risk of death and time until virological rebound (two consecutive VLs >200 copies/ml at least 3 months apart) following suppression., Results: Among 7,080 participants were 497 Indigenous persons of whom 413 (83%) were from British Columbia. The cumulative incidence of suppression 1 year after cART initiation was 54% for Indigenous persons, 77% for Caucasian and 80% for African, Caribbean or Black (ACB) persons. The cumulative incidence of rebound 1 year after suppression was 13% for Indigenous persons, 6% for Caucasian and 7% for ACB persons. Indigenous persons were less likely to achieve suppression than Caucasian participants (aHR=0.58, 95% CI 0.50, 0.68), but not more likely to experience rebound (aHR=1.03, 95% CI 0.84, 1.27) after adjusting for age, gender, injection drug use, men having sex with men status, province of residence, baseline VL and CD4
+ T-cell count, antiretroviral class and year of cART initiation., Conclusions: Lower suppression rates among Indigenous persons suggest a need for targeted interventions to improve HIV health outcomes during the first year of treatment when suppression is usually achieved.- Published
- 2017
- Full Text
- View/download PDF
3. Increase in transmitted HIV drug resistance among persons undergoing genotypic resistance testing in Ontario, Canada, 2002-09.
- Author
-
Burchell AN, Bayoumi AM, Rourke SB, Major C, Gardner S, Sandstrom P, Rachlis A, Taylor D, Mazzulli T, Fisher M, and Brooks J
- Subjects
- Adult, Cohort Studies, Female, HIV isolation & purification, HIV Infections epidemiology, Humans, Male, Middle Aged, Ontario epidemiology, Prevalence, Anti-HIV Agents pharmacology, Drug Resistance, Viral, HIV drug effects, HIV genetics, HIV Infections transmission, HIV Infections virology
- Abstract
Objectives: To characterize persons undergoing HIV genotypic resistance testing (GRT) while treatment naive and to estimate the prevalence of transmitted HIV drug resistance (TDR) among HIV-positive outpatients in Ontario, Canada., Methods: We analysed data from a multi-site cohort of persons receiving HIV care. Data were obtained from medical chart abstractions, interviews and record linkage with the Public Health Laboratories, Public Health Ontario. The analysis was restricted to 626 treatment-naive persons diagnosed in 2002-09. TDR mutations were identified using the calibrated population resistance tool. We used descriptive statistics and regression methods to characterize treatment-naive GRT test uptake and patterns of TDR., Results: Overall, 53.2% (333/626) of participants had baseline GRT. The proportion increased with year of HIV diagnosis from 30.0% in 2002 to 82.6% in 2009 (P < 0.0001). Among those tested, 13.6% (CI 9.9-17.3%) had one or more drug resistance mutations, and 8.8% (CI 5.7-11.8%), 4.8% (CI 2.5-7.2%) and 2.7% (CI 1.0-4.5%) had mutations conferring resistance to nucleoside/tide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs), respectively. TDR prevalence increased from 2002-07 to 2008-09 (adjusted OR 3.7, 95% CI 1.7-8.2), driven by a higher proportion with NRTI (18.2% versus 5.9%, P = 0.0009) and NNRTI mutations (11.7% versus 2.8%, P = 0.004) in the later time period. PI TDR remained unchanged., Conclusions: Baseline GRT increased dramatically since 2002, but remains below 100%. The prevalence of overall TDR tripled due to increases in NRTI and NNRTI mutations. These findings highlight the value of routine baseline GRT for TDR surveillance and patient care.
- Published
- 2012
- Full Text
- View/download PDF
4. Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey
- Author
-
Costiniuk, Cecilia T., Singer, Joel, Needham, Judy, Yang, Yanbo, Qian, Hong, Chambers, Catharine, Burchell, Ann N., Samji, Hasina, Colmegna, Ines, del Canto, Sugandhi, Godin, Guy-Henri, Habanyama, Muluba, Hui, Christian, Kroch, Abigail, Mandarino, Enrico, Margolese, Shari, Martin, Carrie, Owino, Maureen, Mohammadi, Tima, Zhang, Wei, Pelaez, Sandra, Kovacs, Colin, Benko, Erika, Vulesevic, Branka, Cooper, Curtis L., and Anis, Aslam H.
- Published
- 2023
- Full Text
- View/download PDF
5. A national recruitment strategy for HIV-serodiscordant partners living in Canada for the Positive Plus One study: a mixed-methods study
- Author
-
Xi, Min, Bullock, Sandra, Mendelsohn, Joshua B., Iveniuk, James, Moravan, Veronika, Burchell, Ann N., Tan, Darrell H. S., Daftary, Amrita, Thompson, Tamara, Lebouché, Bertrand, Bisaillon, Laura, Myers, Ted, and Calzavara, Liviana
- Published
- 2022
- Full Text
- View/download PDF
6. Influence of previous experience with and beliefs regarding anal cancer screening on willingness to be screened among men living with HIV
- Author
-
Gillis, Jennifer L., Grennan, Troy, Grewal, Ramandip, Ogilvie, Gina, Gaspar, Mark, Grace, Daniel, Lofters, Aisha, Raboud, Janet M., Saarela, Olli, MacPherson, Paul, Rosenes, Ron, Salit, Irving E., and Burchell, Ann N.
- Published
- 2022
- Full Text
- View/download PDF
7. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras
- Author
-
Klein, Marina B, Althoff, Keri N, Jing, Yuezhou, Lau, Bryan, Kitahata, Mari, Re, Vincent Lo, Kirk, Gregory D, Hull, Mark, Kim, H Nina, Sebastiani, Giada, Moodie, Erica EM, Silverberg, Michael J, Sterling, Timothy R, Thorne, Jennifer E, Cescon, Angela, Napravnik, Sonia, Eron, Joe, Gill, M John, Justice, Amy, Peters, Marion G, Goedert, James J, Mayor, Angel, Thio, Chloe L, Cachay, Edward R, Moore, Richard, Research and Design of IeDEA, for the North American AIDS Cohort Collaboration on, Benson, Constance A, Bosch, Ronald J, Boswell, Stephen, Mayer, Kenneth H, Grasso, Chris, Hogg, Robert S, Harrigan, P Richard, Montaner, Julio SG, Samji, Hasina, Brooks, John T, Buchacz, Kate, Gebo, Kelly A, Moore, Richard D, Rodriguez, Benigno, Horberg, Michael A, Jacobsonc, Lisa P, D'Souza, Gypsyamber, Rourke, Sean B, Burchell, Ann N, Rachlis, Anita R, Hunter-Mellado, Robert F, Mayor, Angel M, Deeks, Steven G, Martin, Jeffrey N, Patel, Pragna, Saag, Michael S, Mugavero, Michael J, Willig, James, Eron, Joseph J, Kitahata, Mari M, Crane, Heidi M, Drozd, Daniel R, Haas, David, Bebawy, Sally, Turner, Megan, Justice, Amy C, Dubrow, Robert, Fiellin, David, Gange, Stephen J, Anastos, Kathryn, McKaig, Rosemary G, Freeman, Aimee M, Lent, Carol, Van Rompaey, Stephen E, Morton, Liz, McReynolds, Justin, Lober, William B, and Abraham, Alison G
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Clinical Sciences ,Hepatitis ,Emerging Infectious Diseases ,Chronic Liver Disease and Cirrhosis ,Hepatitis - C ,Digestive Diseases ,Liver Disease ,Hepatitis - B ,Sexually Transmitted Infections ,Infectious Diseases ,HIV/AIDS ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Infection ,Good Health and Well Being ,Adult ,Aged ,Alcohol Drinking ,Anti-HIV Agents ,Canada ,Cohort Studies ,Coinfection ,End Stage Liver Disease ,Female ,HIV Infections ,Hepatitis B ,Hepatitis C ,Humans ,Incidence ,Male ,Middle Aged ,Risk Factors ,United States ,HIV ,hepatitis C virus ,hepatitis B virus ,coinfection ,end-stage liver disease ,North American AIDS Cohort Collaboration on Research and Design of IeDEA ,North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA ,Biological Sciences ,Medical and Health Sciences ,Microbiology ,Clinical sciences - Abstract
BackgroundHuman immunodeficiency virus (HIV)-infected patients coinfected with hepatitis B (HBV) and C (HCV) viruses are at increased risk of end-stage liver disease (ESLD). Whether modern antiretroviral therapy has reduced ESLD risk is unknown.MethodsTwelve clinical cohorts in the United States and Canada participating in the North American AIDS Cohort Collaboration on Research and Design validated ESLD events from 1996 to 2010. ESLD incidence rates and rate ratios according to hepatitis status adjusted for age, sex, race, cohort, time-updated CD4 cell count and HIV RNA were estimated in calendar periods corresponding to major changes in antiretroviral therapy: early (1996-2000), middle (2001-2005), and modern (2006-2010) eras.ResultsAmong 34 119 HIV-infected adults followed for 129 818 person-years, 380 incident ESLD outcomes occurred. ESLD incidence (per 1000 person-years) was highest in triply infected (11.57) followed by HBV- (8.72) and HCV- (6.10) coinfected vs 1.27 in HIV-monoinfected patients. Adjusted incidence rate ratios (95% confidence intervals) comparing the modern to the early antiretroviral era were 0.95 (.61-1.47) for HCV, 0.95 (.40-2.26) for HBV, and 1.52 (.46-5.02) for triply infected patients. Use of antiretrovirals dually activity against HBV increased over time. However, in the modern era, 35% of HBV-coinfected patients were not receiving tenofovir. There was little use of HCV therapy.ConclusionsDespite increasing use of antiretrovirals, no clear reduction in ESLD risk was observed over 15 years. Treatment with direct-acting antivirals for HCV and wider use of tenofovir-based regimens for HBV should be prioritized for coinfected patients.
- Published
- 2016
8. Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study.
- Author
-
Costiniuk, Cecilia T., Lee, Terry, Singer, Joel, Galipeau, Yannick, Arnold, Corey, Langlois, Marc-André, Needham, Judy, Jenabian, Mohammad-Ali, Burchell, Ann N., Samji, Hasina, Chambers, Catharine, Walmsley, Sharon, Ostrowski, Mario, Kovacs, Colin, Tan, Darrell H. S., Harris, Marianne, Hull, Mark, Brumme, Zabrina L., Lapointe, Hope R., and Brockman, Mark A.
- Subjects
BREAKTHROUGH infections ,HIV-positive persons ,HIV infections ,COVID-19 ,ANTIGEN analysis - Abstract
COVID-19 breakthrough infection (BTI) can occur despite vaccination. Using a multi-centre, prospective, observational Canadian cohort of people with HIV (PWH) receiving ≥2 COVID-19 vaccines, we compared the SARS-CoV-2 spike (S) and receptor-binding domain (RBD)-specific IgG levels 3 and 6 months post second dose, as well as 1 month post third dose, in PWH with and without BTI. BTI was defined as positivity based on self-report measures (data up to last study visit) or IgG data (up to 1 month post dose 3). The self-report measures were based on their symptoms and either a positive PCR or rapid antigen test. The analysis was restricted to persons without previous COVID-19 infection. Persons without BTI remained COVID-19-naïve until ≥3 months following the third dose. Of 289 participants, 92 developed BTI (31.5 infections per 100 person-years). The median days between last vaccination and BTI was 128 (IQR 67, 176), with the most cases occurring between the third and fourth dose (n = 59), corresponding to the Omicron wave. In analyses adjusted for age, sex, race, multimorbidity, hypertension, chronic kidney disease, diabetes and obesity, a lower IgG S/RBD (log10 BAU/mL) at 1 month post dose 3 was significantly associated with BTI, suggesting that a lower IgG level at this time point may predict BTI in this cohort of PWH. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Patterns of changing pregnancy intentions among women living with HIV in Canada
- Author
-
Skerritt, Lashanda, Kaida, Angela, O’Brien, Nadia, Burchell, Ann N., Bartlett, Gillian, Savoie, Édénia, Boucoiran, Isabelle, Gormley, Rebecca, Kestler, Mary, Money, Deborah, Loutfy, Mona, and de Pokomandy, Alexandra
- Published
- 2021
- Full Text
- View/download PDF
10. Disparities in the Quality of HIV Care When Using US Department of Health and Human Services Indicators
- Author
-
Althoff, Keri N, Rebeiro, Peter, Brooks, John T, Buchacz, Kate, Gebo, Kelly, Martin, Jeffrey, Hogg, Robert, Thorne, Jennifer E, Klein, Marina, Gill, M John, Sterling, Timothy R, Yehia, Baligh, Silverberg, Michael J, Crane, Heidi, Justice, Amy C, Gange, Stephen J, Moore, Richard, Kitahata, Mari M, Horberg, Michael A, Research and Design, for the North American AIDS Cohort Collaboration on, Kirk, Gregory D, Benson, Constance A, Bosch, Ronald J, Collier, Ann C, Boswell, Stephen, Grasso, Chris, Mayer, Kenneth H, Hogg, Robert S, Harrigan, P Richard, Montaner, Julio SG, Cescon, Angela, Samji, Hasina, Gebo, Kelly A, Moore, Richard D, Carey, John T, Goedert, James J, Jacobson, Lisa P, Klein, Marina B, Rourke, Sean B, Burchell, Ann N, Rachlis, Anita R, Hunter-Mellado, Robert F, Mayor, Angel M, Deeks, Steven G, Martin, Jeffrey N, Saag, Michael S, Mugavero, Michael J, Willig, James, Eron, Joseph J, Napravnik, Sonia, Crane, Heidi M, Dubrow, Robert, Fiellin, David, Haas, David, Bebawy, Sally, Turner, Megan, Anastos, Kathryn, McKaig, Rosemary G, Freeman, Aimee M, Lent, Carol, Van Rompaey, Stephen E, Morton, Liz, McReynolds, Justin, Lober, William B, Abraham, Alison G, Lau, Bryan, Zhang, Jinbing, Jing, Jerry, Golub, Elizabeth, Modur, Shari, Hanna, David B, Wong, Cherise, and Mendes, Adell
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Infectious Diseases ,Behavioral and Social Science ,Prevention ,Sexually Transmitted Infections ,Health Services ,Women's Health ,HIV/AIDS ,Clinical Research ,Infection ,Good Health and Well Being ,Adult ,Aged ,Aged ,80 and over ,Anti-Retroviral Agents ,Cohort Studies ,Continuity of Patient Care ,Cross-Sectional Studies ,Female ,HIV Infections ,Healthcare Disparities ,Humans ,Male ,Middle Aged ,United States ,United States Dept. of Health and Human Services ,Viral Load ,HIV ,quality of care ,retention in care ,antiretroviral therapy ,HIV RNA suppression ,North American AIDS Cohort Collaboration on Research and Design ,Biological Sciences ,Medical and Health Sciences ,Microbiology ,Clinical sciences - Abstract
We estimated US Department of Health and Human Services (DHHS)-approved human immunodeficiency virus (HIV) indicators. Among patients, 71% were retained in care, 82% were prescribed treatment, and 78% had HIV RNA ≤200 copies/mL; younger adults, women, blacks, and injection drug users had poorer outcomes. Interventions are needed to reduce retention- and treatment-related disparities.
- Published
- 2014
11. An evaluation of an employment assistance program focused on people living with HIV in Toronto, Canada.
- Author
-
Perri, Melissa, Hapsari, Ayu Pinky, Craig-Neil, Amy, Ho, Julia, Cattaneo, Jessica, Gaspar, Mark, Hunter, Charlotte, Rueda, Sergio, Burchell, Ann N., and Pinto, Andrew D.
- Subjects
SOCIAL determinants of health ,HUMAN services programs ,RESEARCH funding ,EVALUATION of human services programs ,UNEMPLOYMENT ,INTERVIEWING ,QUANTITATIVE research ,DESCRIPTIVE statistics ,HIV infections ,PSYCHOLOGY of HIV-positive persons ,RESEARCH methodology ,SOCIAL support ,COMPARATIVE studies ,EMPLOYMENT ,COMMUNITY-based social services ,SOCIAL problems - Abstract
Unemployment is more common among people living with HIV (PLWH) compared to the general population. PLWH who are employed have better physical and mental health outcomes compared to unemployed PLWH. The main objective of this mixed-methods study was to conduct a program evaluation of Employment Action (EACT), a community-based program that assists PLWH in Toronto, Ontario, Canada to maintain meaningful employment. We extracted quantitative data from two HIV services databases used by EACT, and collected qualitative data from 12 individuals who had been placed into paid employment through EACT. From 131 clients included in the analysis, 38.1% (n = 50) maintained their job for at least 6 weeks within the first year of enrollment in the EACT program. Gender, ethnicity, age, and first language did not predict employment maintenance. Our interviews highlighted the barriers and facilitators to effective service delivery. Key recommendations include implementing skills training, embedding PLWH as EACT staff, and following up with clients once they gain employment. Investment in social programs such as EACT are essential for strengthening their data collection capacity, active outreach to service users, and sufficient planning for the evaluation phase prior to program implementation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. The impact of drug coverage on viral suppression among people living with HIV in Ontario, Canada
- Author
-
Rachlis, Beth, Light, Lucia, Gardner, Sandra, Burchell, Ann N., Raboud, Janet, Kendall, Claire, McIsaac, Michael A., Murray, James, Rachlis, Anita, and Rourke, Sean B.
- Published
- 2018
- Full Text
- View/download PDF
13. Co-morbid Non-communicable Diseases and Associated Health Service Use in African and Caribbean Immigrants with HIV
- Author
-
Masindi, Khatundi-Irene, Jembere, Nathaniel, Kendall, Claire E., Burchell, Ann N., Bayoumi, Ahmed M., Loutfy, Mona, Raboud, Janet, Rourke, Sean B., Luyombya, Henry, and Antoniou, Tony
- Published
- 2018
- Full Text
- View/download PDF
14. Economic barriers, evidentiary gaps, and ethical conundrums: a qualitative study of physicians’ challenges recommending HPV vaccination to older gay, bisexual, and other men who have sex with men
- Author
-
Grace, Daniel, Gaspar, Mark, Rosenes, Ron, Grewal, Ramandip, Burchell, Ann N., Grennan, Troy, and Salit, Irving E.
- Published
- 2019
- Full Text
- View/download PDF
15. Disclosure of HIV-serodiscordant relationships and association with viral suppression: results from the Positive Plus One study.
- Author
-
Mendelsohn, Joshua B., Calzavara, Liviana, Bullock, Sandra, Iveniuk, James, Tan, Darrell H. S., Burchell, Ann N., Bourne, Adam, Lebouché, Bertrand, Daftary, Amrita, Moravan, Veronika, Loutfy, Mona, and Conway, Brian
- Subjects
CONFIDENCE intervals ,VIRAL load ,CROSS-sectional method ,HIV seroconversion ,SELF-disclosure ,TREATMENT effectiveness ,RESEARCH funding ,DESCRIPTIVE statistics ,CHI-squared test ,SEXUAL partners ,SOCIODEMOGRAPHIC factors - Abstract
Background. Little is known about the effects of disclosure of HIV-serodiscordant relationships on clinical outcomes. We aimed to evaluate the effect of relationship disclosure on HIV viral suppression, and hypothesized that disclosure by HIV-positive and HIV-negative partners would be associated with viral suppression in the HIV-positive partner. Methods. We conducted a Canadian national online and telephone-administered survey of HIV-positive and HIV-negative partners in serodiscordant relationships. The primary outcome was self-reported viral suppression. Multivariable analyses were undertaken using Firth logistic regression. Results. We recruited 540 participants in current serodiscordant relationships (n = 228 HIV-negative; n = 312 HIV-positive). Similar proportions of HIV-positive and HIV-negative partners disclosed their relationship to healthcare professionals (82% v. 76%, p = 0.13). Among HIV-positive partners, disclosure of the relationship to healthcare professionals increased the odds of viral suppression (aOR = 4.7; CI: 2.13, 10.51) after adjusting for age, education, and relationship turmoil due to HIV. Increasing age (aOR = 1.28; 95% CI = 1.07, 1.55) and education (aOR = 2.43; 95% CI = 1.15, 5.26) were also associated with viral suppression. Among HIV-negative partners, relationship disclosure was not associated with viral suppression and HIV-negative heterosexual men were less likely to report that their HIV-positive partners were virally suppressed (aOR = 0.24; CI: 0.09, 0.61). Conclusions. Disclosure of HIV-serodiscordant status by HIV-positive participants to healthcare professionals was associated with increased odds of viral suppression. Similar effects were not evident among HIV-negative participants. Future work should explore factors that empower relationship disclosure and incorporate them into supportive services for HIV-serodiscordant relationships. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Prevalence of Physical Health, Mental Health, and Disability Comorbidities among Women Living with HIV in Canada.
- Author
-
Heer, Emily, Kaida, Angela, O'Brien, Nadia, Kleiner, Bluma, Pierre, Alie, Rouleau, Danielle, Burchell, Ann N., Skerritt, Lashanda, Proulx-Boucher, Karène, Nicholson, Valerie, Loutfy, Mona, and de Pokomandy, Alexandra
- Subjects
HIV-positive women ,MENTAL health ,CHRONIC obstructive pulmonary disease ,GENDER identity ,SOCIAL determinants of health ,INDIVIDUALIZED medicine ,ZIKA virus ,RHINOVIRUSES - Abstract
Life expectancy for people living with HIV has increased, but management of HIV is now more complex due to comorbidities. This study aimed to measure the prevalence of comorbidities among women living with HIV in Canada. We conducted a cross-sectional analysis using data from the 18-months survey (2014–2016) of the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS). Self-report of diagnosed conditions was used to measure lifetime prevalence of chronic physical conditions, current mental health conditions, and disabilities. We examined frequency of overlapping conditions and prevalence stratified by gender identity, ethnicity, and age. Among 1039 participants, 70.1% reported a physical health diagnosis, 57.4% reported a current mental health diagnosis, 19.9% reported a disability, and 47.1% reported both physical and mental health comorbidities. The most prevalent comorbidities were depression (32.3%), anxiety (29.5%), obesity (26.7%, defined as body mass index >30 kg/m
2 ), asthma/chronic obstructive pulmonary disease (23.3%), sleep disorder (22.0%), drug addiction (21.9%), and arthritis/osteoarthritis (20.9%). These results highlight the complexity of HIV care and the important prevalence of comorbidities. Personalized health care that integrates care and prevention of all comorbidities with HIV, with attention to social determinants of health, is necessary to optimize health and well-being of women living with HIV. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
17. Factors and Priorities Influencing Satisfaction with Care among Women Living with HIV in Canada: A Fuzzy Cognitive Mapping Study.
- Author
-
Skerritt, Lashanda, Kaida, Angela, Savoie, Édénia, Sánchez, Margarite, Sarmiento, Iván, O'Brien, Nadia, Burchell, Ann N., Bartlett, Gillian, Boucoiran, Isabelle, Kestler, Mary, Rouleau, Danielle, Loutfy, Mona, and de Pokomandy, Alexandra
- Subjects
HIV-positive women ,COGNITIVE maps (Psychology) ,MEDICAL personnel ,GYNECOLOGIC care ,PARTICIPANT observation ,HIV - Abstract
Engagement along the HIV care cascade in Canada is lower among women compared to men. We used Fuzzy Cognitive Mapping (FCM), a participatory research method, to identify factors influencing satisfaction with HIV care, their causal pathways, and relative importance from the perspective of women living with HIV. Building from a map of factors derived from a mixed-studies review of the literature, 23 women living with HIV in Canada elaborated ten categories influencing their satisfaction with HIV care. The most central and influential category was "feeling safe and supported by clinics and healthcare providers", followed by "accessible and coordinated services" and "healthcare provider expertise". Participants identified factors that captured gendered social and health considerations not previously specified in the literature. These categories included "healthcare that considers women's unique care needs and social contexts", "gynecologic and pregnancy care", and "family and partners included in care." The findings contribute to our understanding of how gender shapes care needs and priorities among women living with HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Routinized Syphilis Screening Among Men Living With Human Immunodeficiency Virus: A Stepped Wedge Cluster Randomized Controlled Trial.
- Author
-
Burchell, Ann N, Tan, Darrell H S, Grewal, Ramandip, MacPherson, Paul A, Walmsley, Sharon, Rachlis, Anita, Andany, Nisha, Mishra, Sharmistha, Gardner, Sandra L, Raboud, Janet, Fisman, David, Cooper, Curtis, Gough, Kevin, Maxwell, John, Rourke, Sean B, Rousseau, Rodney, Mazzulli, Tony, Salit, Irving E, and Allen, Vanessa G
- Subjects
- *
DIAGNOSIS of syphilis , *HIV-positive persons , *EVALUATION of medical care , *PREDICTIVE tests , *CONFIDENCE intervals , *VIRAL load , *SERODIAGNOSIS , *MEN , *MEDICAL screening , *HOSPITAL health promotion programs , *RANDOMIZED controlled trials , *HUMAN services programs , *URBAN hospitals , *HOSPITAL laboratories , *DESCRIPTIVE statistics , *ROUTINE diagnostic tests , *ODDS ratio , *HIV , *OUTPATIENT services in hospitals , *EVALUATION - Abstract
Background We implemented an opt-out clinic-based intervention pairing syphilis tests with routine human immunodeficiency virus (HIV) viral load testing. The primary objective was to determine the degree to which this intervention increased the detection of early syphilis. Methods The Enhanced Syphilis Screening Among HIV-Positive Men (ESSAHM) Trial was a stepped wedge cluster-randomized controlled trial involving 4 urban HIV clinics in Ontario, Canada, from 2015 to 2017. The population was HIV-positive adult males. The intervention was standing orders for syphilis serological testing with viral loads, and control was usual practice. We obtained test results via linkage with the centralized provincial laboratory and defined cases using a standardized clinical worksheet and medical record review. We employed a generalized linear mixed model with a logit link to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of the intervention. Results A total of 3895 men were followed over 7471 person-years. The mean number of syphilis tests increased from 0.53 to 2.02 tests per person per year. There were 217 new diagnoses of syphilis (control, 81; intervention, 136), for which 147 (68%) were cases of early syphilis (control, 61 [75%]; intervention, 86 [63%]). The annualized proportion with newly detected early syphilis increased from 0.009 to 0.032 with implementation of the intervention; the corresponding time-adjusted OR was 1.25 (95% CI,.71–2.20). Conclusions The implementation of standing orders for syphilis testing with HIV viral loads was feasible and increased testing, yet produced less-than-expected increases in case detection compared to past uncontrolled pre–post trials. Clinical Trials Registration NCT02019043. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Patient perspectives on the implementation of routinised syphilis screening with HIV viral load testing: Qualitative process evaluation of the Enhanced Syphilis Screening Among HIV-positive Men trial.
- Author
-
MacKinnon, Kinnon R, Grewal, Ramandip, Tan, Darrell HS, Rousseau, Rodney, Maxwell, John, Walmsley, Sharon, MacPherson, Paul A, Rachlis, Anita, Andany, Nisha, Mishra, Sharmistha, Allen, Vanessa G, and Burchell, Ann N.
- Subjects
PATIENTS' attitudes ,VIRAL load ,SYPHILIS ,HIV-positive men ,HIV - Abstract
Background: Syphilis infections have been on the rise, affecting men living with HIV in urban centres disproportionately. Since individuals in HIV care undergo routine blood testing, HIV clinics provide practical opportunities to conduct regular and frequent syphilis testing. Following the implementation of a routine syphilis testing intervention in HIV outpatient clinics, we conducted a qualitative process evaluation of patient experiences to measure patient acceptability, barriers to implementation, and facilitators of successful uptake.Methods: Upon completion of the trial, which took place at four HIV outpatient clinics in Toronto and Ottawa, Canada, we recruited male patients attending these clinics from November 2017 to April 2018. Interviews were conducted on-site and were audio-recorded and transcribed verbatim. All participants provided written informed consent. Interview data were analyzed using grounded theory, assessing qualitative modulators of effective uptake of routinised syphilis testing.Results: A total of 21 male patients were interviewed. Overall, interviewees found the clinical intervention acceptable, endorsing the practice of routinising syphilis testing alongside regular viral load bloodwork. Some men preferred, based on their self-assessment of syphilis risk, to opt out of testing; we considered this as a potential barrier to uptake of population-wide routinised syphilis testing. Interviewees also identified multiple facilitators of successful uptake, including the de-stigmatising of STI testing as a consequence of the universal nature of routinised testing. Participants recommended a routinised syphilis screening intervention to give patients peace of mind surrounding their sexual health. Participants identified HIV care clinics as comfortable and efficient locations to offer testing.Conclusions: Overall, most men were in support of implementing routinised syphilis testing as part of standard HIV care. From the patient perspective, HIV care clinics are convenient places to be tested for syphilis, and the routine approach was viewed to have a de-stigmatisng effect on syphilis testing.Trial Registration: ClinicalTrials.gov NCT02019043; registered December 23, 2013. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
20. Examining the association between stress and antiretroviral therapy adherence among women living with HIV in Toronto, Ontario.
- Author
-
Benoit, Anita C., Burchell, Ann N., O'Brien, Kelly K., Raboud, Janet, Gardner, Sandra, Light, Lucia, Beaver, Kerrigan, Cotnam, Jasmine, Conway, Tracey, Price, Colleen, Rourke, Sean B., Rueda, Sergio, Hart, Trevor A., and Loutfy, Mona
- Subjects
HIV-positive women ,ANTIRETROVIRAL agents ,ALCOHOLISM ,ALCOHOL drinking ,HIV ,HISTORY in art - Abstract
Background: We aimed to identify the association between stress and antiretroviral therapy (ART) adherence among women in HIV care in Toronto, Ontario participating in the Ontario HIV Treatment Network Cohort Study (OCS) between 2007 and 2012. Materials and methods: We conducted cross-sectional analyses with women on ART completing the AIDS Clinical Trial Group (ACTG) Adherence Questionnaire. Data closest to, or at the last completed interview, were collected from medical charts, through record linkage with Public Health Ontario Laboratories, and from a standardized self-reported questionnaire comprised of socio-demographic and psycho-socio-behavioral measures (Center for Epidemiologic Studies Depression Scale (CES-D), Alcohol Use Disorders Identification Test (AUDIT)), and stress measures (National Population Health Survey). Logistic regression was used to quantify associations with optimal adherence (=95% adherence defined as missing = one dose of ART in the past 4 weeks). Results: Among 307 women, 65.5% had optimal adherence. Women with suboptimal compared to optimal adherence had higher median total stress scores (6.0 [interquartile range (IQR): 3.0-8.1] vs. 4.1 [IQR: 2.0-7.1], p = 0.001), CES-D scores (16 [IQR: 6-28] vs. 12 [IQR: 3-22], p = 0.008) and reports of hazardous and harmful alcohol use (31.1% vs. 17.9%, p = 0.008). In our multivariable model, we found an increased likelihood of optimal adherence with the absence of hazardous and harmful alcohol use (Adjusted Odds Ratio (AOR)=2.20, 95% confidence interval (CI): 1.12-4.32) and a decreased likelihood of optimal adherence with more self-reported stress (AOR = 0.56, 95% CI: 0.33-0.94). Conclusions: Interventions supporting optimal ART adherence should address stress and include strategies to reduce or eliminate hazardous and harmful alcohol use for women living with HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
21. Population-Level Sexual Mixing According to HIV Status and Preexposure Prophylaxis Use Among Men Who Have Sex With Men in Montreal, Canada: Implications for HIV Prevention.
- Author
-
Wang, Linwei, Moqueet, Nasheed, Lambert, Gilles, Grace, Daniel, Rodrigues, Ricky, Cox, Joseph, Lachowsky, Nathan J, Noor, Syed W, Armstrong, Heather L, Tan, Darrell H S, Burchell, Ann N, Ma, Huiting, Apelian, Herak, Knight, Jesse, Messier-Peet, Marc, Jollimore, Jody, Baral, Stefan, Hart, Trevor A, Moore, David M, and Mishra, Sharmistha
- Subjects
HIV prevention ,COMPARATIVE studies ,CONFIDENCE intervals ,PREVENTIVE medicine ,SURVEYS ,CROSS-sectional method ,HIV seroconversion ,MEN who have sex with men ,SEXUAL partners ,DESCRIPTIVE statistics ,HIV seronegativity - Abstract
Using cross-sectional survey data (Engage, 2017–2018) from 1,137 men who have sex with men, ≥16 years old, in Montreal, we compared observed human immunodeficiency virus (HIV) seroconcordance in previous-6-months' sexual partnerships with what would have been observed by chance if zero individuals serosorted. Of 5 recent partnerships where both individuals were HIV-negative, we compared observed concordance in preexposure prophylaxis (PrEP) use with the counterfactual if zero individuals selected partners based on PrEP use. We estimated the concordance by chance using a balancing-partnerships approach assuming proportionate mixing. HIV-positive respondents had a higher proportion of HIV-positive partners (66.4%, 95% confidence interval (CI): 64.0, 68.6) than by chance (23.9%, 95% CI: 23.1, 24.7). HIV-negative respondents (both on and not on PrEP) had higher proportions of HIV-negative partners (82.9% (95% CI: 81.1, 84.7) and 90.7% (95% CI: 89.6, 91.7), respectively) compared with by chance (76.1%, 95% CI: 75.3, 76.9); however, those on PrEP had a higher proportion of HIV-positive partners than those not on PrEP (17.1% (95% CI: 15.3, 18.9) vs. 9.3% (95% CI: 8.3, 10.4). Those on PrEP also had a higher proportion of partners on PrEP among their HIV-negative partners (50.6%, 95% CI: 42.5, 58.8) than by chance (28.5%, 95% CI: 27.5, 29.4). The relationship between PrEP and sexual-mixing patterns demonstrated by less population-level serosorting among those on PrEP and PrEP-matching warrants consideration during PrEP roll-out. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Trends in HIV care cascade engagement among diagnosed people living with HIV in Ontario, Canada: A retrospective, population-based cohort study.
- Author
-
Wilton, James, Liu, Juan, Sullivan, Ashleigh, Rachlis, Beth, Marchand-Austin, Alex, Giles, Madison, Light, Lucia, Rank, Claudia, Burchell, Ann N., Gardner, Sandra, Sider, Doug, Gilbert, Mark, Kroch, Abigail E., and null, null
- Subjects
HIV ,DIAGNOSIS of HIV infections ,VIRAL load ,HIV-positive persons ,MICROBIAL virulence - Abstract
Background: The HIV cascade is an important framework for assessing systems of care, but population-based assessment is lacking for most jurisdictions worldwide. We measured cascade indicators over time in a population-based cohort of diagnosed people living with HIV (PLWH) in Ontario, Canada. Methods: We created a retrospective cohort of diagnosed PLWH using a centralized laboratory database with HIV diagnostic and viral load (VL) test records linked at the individual-level. Individuals enter the cohort with record of a nominal HIV-positive diagnostic test or VL test, and remain unless administratively lost to follow-up (LTFU, >2 consecutive years with no VL test and no VL test in later years). We calculated the annual percent of diagnosed PLWH (cohort individuals not LTFU) between 2000 and 2015 who were in care (≥1 VL test), on ART (as documented on VL test requisition) or virally suppressed (<200 copies/ml). We also calculated time from diagnosis to linkage to care and viral suppression among individuals newly diagnosed with HIV. Analyses were stratified by sex and age. Upper/lower bounds were calculated using alternative indicator definitions. Results: The number of diagnosed PLWH increased from 8,859 (8,859–11,389) in 2000 to 16,110 (16,110–17,423) in 2015. Over this 16-year period, the percent of diagnosed PLWH who were: in care increased from 81% (63–81%) to 87% (81–87%), on ART increased from 55% (34–60%) to 81% (70–82%) and virally suppressed increased from 41% (23–46%) to 80% (67–81%). Between 2000 and 2014, the percent of newly diagnosed individuals who linked to care within three months of diagnosis or achieved viral suppression within six months of diagnosis increased from 67% to 82% and from 22% to 42%, respectively. Estimates were generally lower for females and younger individuals. Discussion: HIV cascade indicators among diagnosed PLWH in Ontario improved between 2000 and 2015, but gaps still remain—particularly for younger individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
23. Outcomes Among Persons with HIV Following a Mental Health Admission: A Population-Based Study.
- Author
-
Lau, Cindy, Kendall, Claire E., Burchell, Ann N., Bayoumi, Ahmed M., Loutfy, Mona, Rourke, Sean B., and Antoniou, Tony
- Abstract
To compare outcomes following psychiatric hospitalization between people with and without HIV. Population-based study of people with (
n = 1,089) and without (n = 280,888) HIV who were hospitalized for psychiatric illness between January 1, 2006 and December 31, 2014. Overall, 9 (0.8%) people with HIV died within 30 days of discharge, compared with 3,710 (1.3%) HIV-negative individuals. Following multivariable adjustment, there was no difference in the risk of readmission or emergency department (ED) visits for psychiatric illness in the 90 days following discharge. Conversely, people with HIV were at higher risk of ED visits for substance use disorders and less likely to receive psychiatry follow-up during this period. HIV is associated with ED use for substance use disorders and less psychiatry follow-up within 90 days of hospital discharge for psychiatric illness. Interventions facilitating continuity of care following discharge are warranted. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
24. Cervical cancer screening uptake among HIV-positive women in Ontario, Canada: A population-based retrospective cohort study.
- Author
-
Burchell, Ann N., Kendall, Claire E., Cheng, Stephanie Y., Lofters, Aisha, Cotterchio, Michelle, Bayoumi, Ahmed M., Glazier, Richard H., Antoniou, Tony, Raboud, Janet, Yudin, Mark H., and Loutfy, Mona
- Subjects
- *
EARLY detection of cancer , *CERVICAL cancer , *HIV-positive women , *EPIDEMICS , *GUIDELINES , *DISEASES - Abstract
Cervical cancer caused by oncogenic types of the human papillomavirus (HPV) is of concern among HIV-positive women due to impairment of immune responses required to control HPV infection. Our objectives were to describe patterns of cervical cancer screening using Pap cytology testing among HIV-positive women in Ontario, Canada from 2008 to 2013 and to identify factors associated with adequate screening. We conducted a retrospective, population-based cohort study among screen-eligible HIV-positive women using provincial administrative health data. We estimated annual proportions tested and reported these with 95% confidence intervals (CI). Next, using person-years as the unit of analysis, we identified factors associated with annual Pap testing using log-binomial regression. A total of 2271 women were followed over 10,697 person-years. In 2008, 34.0% (95%CI 31.1-37.0%) had a Pap test. By 2013, the proportion of HIV-positive women tested was 25.9% (95%CI 23.6-28.2%). Women who were most likely to undergo testing were younger, were immigrants from countries with generalized HIV epidemics, lived in the highest income neighbourhoods, had a female primary care physician, had two or more encounters per year with an infectious disease or internal medicine specialist, and had greater comorbidity. Nearly three in four HIV-positive women were under-screened despite all having universal insurance for medically-necessary services. Annual Pap testing decreased following the 2011-2013 release of new guidelines for a lengthened screen interval for average risk women and a billing disincentive. Clinic-based intervention such as physician alerts or reminders may be needed to improve screening coverage among HIV-positive women. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
25. High retention in HIV care at a tertiary care centre in Toronto, Canada.
- Author
-
Szadkowski, Leah, Walmsley, Sharon, Burchell, Ann N., Collins, Evan, Rourke, Sean B., and Raboud, Janet
- Subjects
AGE distribution ,MENTAL depression ,DRUGS of abuse ,PSYCHOLOGY of HIV-positive persons ,MULTIVARIATE analysis ,PATIENT compliance ,QUESTIONNAIRES ,RACE ,SAMPLE size (Statistics) ,VIRAL load ,INTRAVENOUS drug abusers ,PATIENT dropouts ,DISEASE duration ,DATA analysis software ,DESCRIPTIVE statistics ,CD4 lymphocyte count ,TERTIARY care - Abstract
Poor retention in HIV care is associated with poor clinical outcomes and mortality. Previous studies of predictors of poor retention have been conducted with a wide variety of populations, using different measures of retention, and occasionally have conflicting results. We studied demographic and psychosocial factors associated with inter-visit interval length in a setting of universal health care and modern cART. Patients attending ≥2 appointments with an HIV specialist at the Toronto General Hospital Immunodeficiency Clinic from 2004 to 2013 were studied. A sub-analysis included psychosocial measures from annual questionnaires for Ontario HIV Treatment Network Cohort Study (OCS) participants. Median inter-visit interval and constancy (percentage of 4-month intervals with ≥1 visit) were calculated by patient. Multivariable generalized estimating equation models identified factors associated with inter-visit interval length and intervals ≥12 months. 1591 patients were included. 615 patients completed an OCS questionnaire and were more likely to be older white MSM from Canada with a viral load (VL) <50 copies/ml. The median (IQR) of patients’ median inter-visit intervals was 3.15 (2.78, 3.84) months and median (IQR) constancy was 90% (71%, 100%). Two percent of inter-visit intervals were ≥12 months and 25% of patients had ≥1 interval ≥12 months. Longer inter-visit intervals were associated with younger age, white race, earlier calendar year, longer duration of HIV, VL < 50 copies/mL and higher CD4 counts. Patients who were younger, white, had injection drug use as a risk factor, had a longer duration of HIV, and had VL ≥50 copies/mL were more likely to have an inter-visit interval ≥12 months. In the OCS sub-analysis including psychosocial variables, lower levels of depression were associated with longer inter-visit intervals. Retention at this tertiary care centre was high. Efforts to maximize attendance should focus on younger patients and those with substance abuse issues. [ABSTRACT FROM PUBLISHER]
- Published
- 2018
- Full Text
- View/download PDF
26. Mortality and Health Service Use Following Acute Myocardial Infarction Among Persons with HIV: A Population-Based Study.
- Author
-
Jeon, Caroline, Lau, Cindy, Kendall, Claire E., Burchell, Ann N., Bayoumi, Ahmed M., Loutfy, Mona, Rourke, Sean B., and Antoniou, Tony
- Abstract
People with HIV have higher rates of acute myocardial infarction (AMI) than HIV-negative individuals. We compared mortality risk and health service use following AMI among people with and without HIV between January 1, 2002, and March 31, 2015. We conducted a population-based study using Ontario's administrative databases. Our primary outcomes were risk of inpatient death and death at 30 days following hospital discharge. In secondary analyses, we compared use of revascularization procedures within 90 days of AMI, as well as readmission or emergency department visits for heart disease and cardiology follow-up within 90 days of discharge. We studied 259,475 AMI patients, of whom 345 (0.13%) were people with HIV. AMI patients with HIV were younger than HIV-negative patients (mean age ± standard deviation: 54.4 ± 10.5 years vs. 69.3 ± 14.3 years). Following multivariable adjustment, the odds ratios for inpatient death and death at 30 days following discharge were 1.04 [95% confidence intervals (CI) 0.64-1.56] and 2.42 (95% CI 1.00-4.92), respectively. In secondary analyses, no differences were observed in receipt of revascularization procedures (hazard ratio (HR) 0.98; 95% CI 0.85-1.12), readmission or emergency department visit for heart disease (HR 1.18; 95% CI 0.85-1.62), or cardiology follow-up (HR 0.88; 95% CI 0.76-1.01). People with HIV experience AMI at younger ages and may be at higher risk of death in the 30 days following hospital discharge, underscoring the importance of targeting modifiable cardiovascular disease risk factors in these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
27. Understanding the Correlates of Attrition Associated with Antiretroviral Use and Viral Suppression Among Women Living with HIV in Canada.
- Author
-
Kronfli, Nadine, Lacombe-Duncan, Ashley, Wang, Lu, de Pokomandy, Alexandra, Kaida, Angela, Logie, Carmen H., Conway, Tracey, Kennedy, V. Logan, Burchell, Ann N., Tharao, Wangari, Pick, Neora, Kestler, Mary, Sereda, Paul, and Loutfy, Mona
- Subjects
STATISTICAL correlation ,HIV-positive persons ,MULTIVARIATE analysis ,RACISM ,STATISTICS ,VIRUS inactivation ,LOGISTIC regression analysis ,VIRAL load ,DRUG abusers ,HIGHLY active antiretroviral therapy ,FOOD security ,PATIENT dropouts ,DESCRIPTIVE statistics ,PSYCHOLOGY - Abstract
Attrition along the cascade of HIV care compromises attainment of the UNAIDS 90-90-90 goals and achievement of desirable treatment outcomes for people living with HIV. Given known gender disparities in HIV care and outcomes, understanding the correlates of attrition at stages of the care cascade for women living with HIV (WLWH) is essential. Among the 1425 WLWH enrolled in the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS), we measured the proportion who reported not being currently on combination antiretroviral therapy (cART) and the proportion who reported a detectable viral load (VL; ≥40 copies/mL) despite cART use. Correlates of these cascade indicators were examined using univariate and multivariable logistic regression. Overall, 14.8% of women were not currently on cART. Of women who were on cART, 9.0% were not virally suppressed. In multivariable analyses, age between 26 and 34, unstable housing, food insecurity, current injection drug use, higher HIV-related stigma, and racial discrimination were associated with increased odds of not being on cART. Factors associated with increased odds of reporting a detectable VL among women on cART included age ≤34 years, less than a secondary education, unstable housing, and incarceration in the previous year. Programmatic efforts to support cART use and viral suppression for WLWH in Canada should focus on social determinants of health, including housing and food insecurity, social exclusion, and education. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
28. The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
- Author
-
de Pokomandy, Alexandra, Kaufman, Elaina, de Castro, Christina, Mayrand, Marie-Hélène, Burche, Ann N., Klein, Marina, Charest, Louise, Auger, Manon, Rodrigues-Coutlée, Sophie, Coutlée, François, Burchell, Ann N, and EVVA Study Group
- Subjects
PAPILLOMAVIRUS disease diagnosis ,PAPILLOMAVIRUS pathogenicity ,HUMAN papillomavirus vaccines ,CYTOLOGY ,HIV prevention ,HIV infections ,THERAPEUTICS ,ANTIRETROVIRAL agents ,HIV infection epidemiology ,ANUS ,CERVIX uteri ,GENETIC techniques ,LONGITUDINAL method ,PAPILLOMAVIRUS diseases ,PAPILLOMAVIRUSES ,DISEASE prevalence - Abstract
Background: The risk of anal cancer due to high-risk human papillomavirus (HR-HPV) is higher in women living with human immunodeficiency virus (HIV) than in the general population. We present findings of cervical and anal HPV and cytologic tests at baseline in the EVVA cohort study and HPV persistence data 6 months after baseline.Methods: Semiannual visits included questionnaires, chart reviews, cervical/anal cytologic and cervical/anal HPV testing for 2 years. Genotyping for 36 HPV genotypes was performed using the Roche Linear Array HPV genotyping test.Results: A total of 151 women living with HIV were recruited. At baseline, 75% had anal HPV, 51% had anal HR-HPV, 50% had cervical HPV, and 29% had cervical HR-HPV. Anal HPV-16 and HPV-51 were more frequent in women born in Canada (31% and 29%, respectively, compared with ≤16% for other women). Most anal HR-HPV types detected at 6 months (57%-93%) were persistent from baseline. Findings of anal cytologic tests were abnormal for 37% of women.Conclusions: Anal HPV is highly prevalent in women living with HIV, and type distribution varies by place of birth. High-resolution anoscopy was indicated in more than one third of results. As anal cancer is potentially preventable, these important findings need to be considered when selecting the best approach for anal cancer screening programs. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
29. Social determinants of health and retention in HIV care in a clinical cohort in Ontario, Canada.
- Author
-
Rachlis, Beth, Burchell, Ann N., Gardner, Sandra, Light, Lucia, Raboud, Janet, Antoniou, Tony, Bacon, Jean, Benoit, Anita, Cooper, Curtis, Kendall, Claire, Loutfy, Mona, Wobeser, Wendy, McGee, Frank, Rachlis, Anita, and Rourke, Sean B.
- Subjects
- *
AGE distribution , *DRUGS , *HIV infections , *INTERVIEWING , *PATIENT compliance , *PROBABILITY theory , *RACE , *SEX distribution , *LOGISTIC regression analysis , *VIRAL load , *ANTIRETROVIRAL agents , *PATIENT refusal of treatment , *HEALTH & social status , *ODDS ratio - Abstract
Continuous HIV care supports antiretroviral therapy initiation and adherence, and prolongs survival. We investigated the association of social determinants of health (SDH) and subsequent retention in HIV care in a clinical cohort in Ontario, Canada. The Ontario HIV Treatment Network Cohort Study is a multi-site cohort of patients at 10 HIV clinics. Data were collected from medical charts, interviews, and via record linkage with the provincial public health laboratory for viral load tests. For participants interviewed in 2009, we used three-category multinomial logistic regression to identify predictors of retention in 2010-2012, defined as (1) continuous care (=2 viral loads =90 days in all years; reference category); (2) discontinuous care (only 1 viral load/year in =1 year); and (3) a gap in care (=1 year in 2010-2012 with no viral load). In total, 1838 participants were included. In 2010-2012, 71.7% had continuous care, 20.9% had discontinuous care, and 7.5% had a gap in care. Discontinuous care in 2009 was predictive (p < .0001) of future retention. SDH associated with discontinuous care were Indigenous ethnicity, being born in Canada, being employed, reporting hazardous drinking, and non-injection drug use. Being a heterosexual male was associated with having a gap in care, and being single and younger were associated with discontinuous care and a gap in care. Various SDH were associated with retention. Care discontinuity was highly predictive of future gaps. Targeted strategic interventions that better engage those at risk of suboptimal retention merit exploration. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
30. Sociodemographic and Health Profile of Heterosexual Men Living With HIV in Ontario, Canada.
- Author
-
Wheeler, Kristen M., Antoniou, Tony, Gardner, Sandra, Light, Lucia, Grewal, Ramandip, Globerman, Jason, Husbands, Winston, and Burchell, Ann N.
- Abstract
In Ontario, Canada, the number of heterosexual men living with HIV has increased over time, yet they remain an understudied population. The study objective was to describe the sociodemographic and clinical characteristics of this population, using data from a multisite clinical cohort of patients receiving HIV care. Sociodemographic and clinical characteristics of men interviewed between 2010 and 2012 were compared according to their self-identified sexual orientation, followed by multivariable linear and logistic regression to assess the association of sexual orientation with CD4 cell count, viral load, hepatitis C co-infection, self-rated health, and mental health concerns after adjustment for covariates. A total of 552 men identified as heterosexual, 2,023 as gay, and 171 as bisexual. Compared to gay and bisexual men, heterosexual men were more likely to have been born outside of Canada (34.8%); more likely to report African, Caribbean, or Black ethnicity (26.4%) or Indigenous ethnicity (13.6%); and more likely to have low socioeconomic status (59.5% earning less than $20,000 per year), and/or a history of injection drug use (31.7%). Relative to gay men, heterosexual men had 5.19 times the odds of co-infection with hepatitis C virus regardless of injection drug use history (95% confidence interval = 3.87-6.96), and 40% lower odds of rating their health as excellent or good (95% confidence interval = 0.50-0.84). HIV-positive heterosexual men in Ontario constituted a socially marginalized group characterized by a high prevalence of injection drug use history and hepatitis C co-infection. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
31. Sexual behaviors among women living with HIV in Ontario, Canada.
- Author
-
Robinson, Samantha, Gardner, Sandra, Loutfy, Mona, Light, Lucia, Tharao, Wangari, Rourke, Sean B., and Burchell, Ann N.
- Subjects
BLACK people ,CHI-squared test ,INFECTIOUS disease transmission ,CONDOMS ,HIV infections ,INDIGENOUS peoples ,INTERVIEWING ,PROBABILITY theory ,RESEARCH funding ,HUMAN sexuality ,WHITE people ,WOMEN'S health ,LOGISTIC regression analysis ,UNSAFE sex ,HIV seroconversion ,DATA analysis software ,SEXUAL partners - Abstract
Understanding the sexual activities and partnerships of women living with human immunodeficiency virus (HIV) remains important to promote healthy sexuality and to reduce the transmission of HIV and other sexually transmitted infections. We described sexual behaviors of women living with HIV enrolled in an ongoing study in Ontario, Canada. Data were available from 582 women who self-completed a sexual behavior questionnaire between 2010 and 2012. Nearly half (46.1%) of women reported a sexual partner in the preceding three months; women less likely to be sexually active were older, Black/African, separated, divorced, widowed, single, and unemployed. Most sexually active women had one partner (76.4%), a regular partner (75.9%), male (96.2%) partner(s), and partners who were HIV-negative or unknown HIV status (75.2%). Women were more likely to use a condom with HIV-negative/status unknown partners (81.3%) than with HIV-positive partners (58.6%;p = .008). Only 8.0% of sexually active women reported condomless sex with a discordant HIV-negative/status unknown partner when their viral load was detectable. Overall, most women living with HIV were sexually inactive or engaged in sexual activities that were low risk for HIV transmission. [ABSTRACT FROM PUBLISHER]
- Published
- 2017
- Full Text
- View/download PDF
32. Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients.
- Author
-
Antoniou, Tony, Szadkowski, Leah, Walmsley, Sharon, Cooper, Curtis, Burchel, Ann N., Bayoumi, Ahmed M., Montaner, Julio S. G., Loutfy, Mona, Klein, Marina B., Machouf, Nima, Tsoukas, Christos, Wong, Alexander, Hogg, Robert S., Raboud, Janet, Burchell, Ann N, and Canadian Observational Cohort (CANOC) collaboration
- Subjects
ATAZANAVIR ,HIV-positive persons ,RITONAVIR ,HIV protease inhibitors ,VIROLOGY ,COMBINATION drug therapy ,COMPARATIVE studies ,HIV ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,RESEARCH funding ,EVALUATION research ,RETROSPECTIVE studies ,ANTI-HIV agents ,THERAPEUTICS - Abstract
Background: Atazanavir/ritonavir and darunavir/ritonavir are common protease inhibitor-based regimens for treating patients with HIV. Studies comparing these drugs in clinical practice are lacking.Methods: We conducted a retrospective cohort study of antiretroviral naïve participants in the Canadian Observational Cohort (CANOC) collaboration initiating atazanavir/ritonavir- or darunavir/ritonavir-based treatment. We used separate Fine and Gray competing risk regression models to compare times to regimen failure (composite of virologic failure or discontinuation for any reason). Additional endpoints included virologic failure, discontinuation due to virologic failure, discontinuation for other reasons, and virologic suppression.Results: We studied 222 patients treated with darunavir/ritonavir and 1791 patients treated with atazanavir/ritonavir. Following multivariable adjustment, there was no difference between darunavir/ritonavir and atazanavir-ritonavir in the risk of regimen failure (adjusted hazard ratio 0.76, 95% CI 0.56 to 1.03) Darunavir/ritonavir-treated patients were at lower risk of virologic failure relative to atazanavir/ritonavir treated patients (aHR 0.50, 95% CI 0.28 to 0.91), findings driven largely by high rates of virologic failure among atazanavir/ritonavir-treated patients in the province of British Columbia. Of 108 discontinuations due to virologic failure, all occurred in patients starting atazanavir/ritonavir. There was no difference between regimens in time to discontinuation for reasons other than virologic failure (aHR 0.93; 95% CI 0.65 to 1.33) or virologic suppression (aHR 0.99, 95% CI 0.82 to 1.21).Conclusions: The risk of regimen failure was similar between patients treated with darunavir/ritonavir and atazanavir/ritonavir. Although darunavir/ritonavir was associated with a lower risk of virologic failure relative to atazanavir/ritonavir, this difference varied substantially by Canadian province and likely reflects regional variation in prescribing practices and patient characteristics. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
33. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
- Author
-
Rossi, Carmine, Raboud, Janet, Walmsley, Sharon, Cooper, Curtis, Antoniou, Tony, Burchell, Ann N., Hull, Mark, Chia, Jason, Hogg, Robert S., Moodie, Erica E. M., Klein, Marina B., and Canadian Observational Cohort (CANOC) Collaboration
- Subjects
ANTIRETROVIRAL agents ,AIDS treatment ,HIV-positive persons ,MIXED infections ,KIDNEY diseases ,HIV infection complications ,HIV infection epidemiology ,CHRONIC kidney failure ,GLOMERULAR filtration rate ,HEPATITIS C ,HEPATITIS viruses ,LONGITUDINAL method ,RESEARCH funding ,PROPORTIONAL hazards models ,DISEASE complications - Abstract
Background: Combination antiretroviral therapy (cART) has reduced mortality from AIDS-related illnesses and chronic comorbidities have become prevalent among HIV-infected patients. We examined the association between hepatitis C virus (HCV) co-infection and chronic kidney disease (CKD) among patients initiating modern antiretroviral therapy.Methods: Data were obtained from the Canadian HIV Observational Cohort for individuals initiating cART from 2000 to 2012. Incident CKD was defined as two consecutive serum creatinine-based estimated glomerular filtration (eGFR) measurements <60 mL/min/1.73m2 obtained ≥3 months apart. CKD incidence rates after cART initiation were compared between HCV co-infected and HIV mono-infected patients. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using multivariable Cox regression.Results: We included 2595 HIV-infected patients with eGFR >60 mL/min/1.73m2 at cART initiation, of which 19% were HCV co-infected. One hundred and fifty patients developed CKD during 10,903 person-years of follow-up (PYFU). The CKD incidence rate was higher among co-infected than HIV mono-infected patients (26.0 per 1000 PYFU vs. 10.7 per 1000 PYFU). After adjusting for demographics, virologic parameters and traditional CKD risk factors, HCV co-infection was associated with a significantly shorter time to incident CKD (HR 1.97; 95% CI: 1.33, 2.90). Additional factors associated with incident CKD were female sex, increasing age after 40 years, lower baseline eGFR below 100 mL/min/1.73m2, increasing HIV viral load and cumulative exposure to tenofovir and lopinavir.Conclusions: HCV co-infection was associated with an increased risk of incident CKD among HIV-infected patients initiating cART. HCV-HIV co-infected patients should be monitored for kidney disease and may benefit from available HCV treatments. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
34. Burden and risk factors for gastrointestinal symptom distress in HIV patients in the modern antiretroviral era.
- Author
-
O'Neill, Tyler J., Raboud, Janet M., Tinmouth, Jill, Rourke, Sean B., Gardner, Sandra, Cooper, Curtis, Rueda, Sergio, Hart, Trevor A., Rachlis, Anita, and Burchell, Ann N.
- Subjects
GASTROINTESTINAL diseases ,CONFIDENCE intervals ,GAY men ,HIV infections ,LONGITUDINAL method ,MULTIVARIATE analysis ,QUESTIONNAIRES ,RESEARCH funding ,SCALE analysis (Psychology) ,ANTIRETROVIRAL agents ,HIGHLY active antiretroviral therapy ,ODDS ratio ,DISEASE risk factors - Abstract
In the modern antiretroviral (ARV) era, there is limited knowledge about the prevalence and risk factors for HIV patient-reported gastrointestinal (GI) symptoms (diarrhoea/soft stool, nausea/vomiting, bloating/painful abdomen, loss of appetite, and weight loss/wasting) and distress. We prospectively analysed data (2007–2014) on distressing GI symptoms from the Ontario HIV Treatment Network Cohort Study, which follows people attending HIV clinics. Using generalized estimating equations with a logit link, we estimated the associations of psychosocial, demographic, behavioural, and clinical factors with each GI symptoms compared to asymptomatic and non-bothersome symptoms. Among 1532 included participants, 80.4% were male, mean age was 45 years, and 64.6% reported being men who have sex with men. Most were Caucasian (56.3%), a median time since HIV diagnosis of 9.8 years (interquartile range (IQR): 4.1–16.9), and 83.1% were on ARV. More than two-thirds (68.7% (95% confidence intervals (CI): 63.1% to 69.2%)) reported one or more symptoms with a median of 1.2 (IQR: 0–1.7). The proportion remained stable over time since HIV diagnosis and ARV initiation. Risk factors varied for multivariable models. A strong association with Centre for Epidemiologic Studies Depression scale scores of ≥23 was found for all symptoms. Adjusted odds ratios (95% CI) were 1.72 (1.39–2.12), 2.95 (2.33–3.72), 2.20 (1.81–2.68), 4.97 (3.99–6.19), and 2.98 (2.52–3.82) for diarrhoea, nausea/vomiting, bloating, loss of appetite, and weight loss, respectively. With the exception of bloating, odds were significantly lower for those on ARV containing integrase inhibitors and greater for patients reporting current cannabis use. GI symptoms in the modern ARV era are highly prevalent and may arise as a common pathway of distress in response to psychosocial vulnerabilities, regardless of the stage of diagnosis. These findings support the need for integrated approaches to address psychological and physical distress in HIV disease. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
35. Developing a performance framework for measuring comprehensive, community-based primary healthcare for people with HIV.
- Author
-
Johnston, Sharon, Hogel, Matthew, Burchell, Ann N., Rebick, Gabriel, Antoniou, Tony, McLaren, Meaghan, Loutfy, Mona, Liddy, Clare, and Kendall, Claire
- Subjects
CLINICAL competence ,CLINICAL medicine ,HIV-positive persons ,INTERVIEWING ,RESEARCH methodology ,MEDICAL quality control ,MEDICAL screening ,PRIMARY health care ,RESEARCH funding ,STATISTICAL sampling ,SOCIAL services ,EMAIL ,JUDGMENT sampling ,KEY performance indicators (Management) ,DATA analysis software ,HEALTH & social status - Abstract
ObjectivesPeople with human immunodeficiency virus (HIV) are living longer lives and like many other patients, need a health system better adapted for the management of complex chronic conditions. A key element of system transformation is measuring and reporting on system performance indicators relevant to the different stakeholders. Our objective was to produce a performance measurement framework for assessing the quality of comprehensive community-based primary healthcare for people with HIV.MethodsSemi-structured interviews were performed with HIV providers, advocates, and policy-makers to obtain input on a draft performance framework, constructed using existing HIV-specific indicators, as well as the use of performance data in improving care for people with HIV.ResultsStakeholders were overwhelmingly supportive of the framework’s comprehensiveness. Many noted the absence of indicators addressing social determinants of health and had mixed opinions on the importance of indicators addressing access to after-hours care and the frequency of routine screening for behavioural risk factors. The draft framework was modified to reflect stakeholder input, triangulated against expert opinion and recently released HIV care guidelines, and finalized at 79 indicators. The resources and infrastructure to collect and use performance data will have to be improved for performance measurement to contribute to improving care for people with HIV.ConclusionsThis framework presents a comprehensive though not exhaustive tool to support performance measurement and improvement in the care for people with HIV. However, advances in data collection and use across the system will be needed to support performance measurement driving quality improvement. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
36. Enhanced syphilis screening among HIV-positive men (ESSAHM): a study protocol for a clinic-randomized trial with stepped wedge design.
- Author
-
Burchell, Ann N., Allen, Vanessa G., Grewal, Ramandip, MacPherson, Paul A., Rachlis, Anita, Walmsley, Sharon, Mishra, Sharmistha, Gardner, Sandra L., Raboud, Janet, Cooper, Curtis, Gough, Kevin, Rourke, Sean B., Rousseau, Rodney, Salit, Irving, and Tan, Darrell H. S.
- Subjects
- *
SYPHILIS epidemiology , *DIAGNOSIS of HIV infections , *MEN who have sex with men , *RANDOMIZED controlled trials , *OUTPATIENT services in hospitals , *DIAGNOSIS of syphilis , *SYPHILIS prevention , *HIV infection complications , *CLINICAL trials , *COMPARATIVE studies , *HOMOSEXUALITY , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *MEDICAL screening , *RESEARCH , *RESEARCH funding , *CITY dwellers , *EVALUATION research , *EARLY diagnosis , *MIXED infections - Abstract
Background: The current syphilis epidemic among urban men who have sex with men (MSM) has serious implications for those co-infected with human immunodeficiency virus (HIV). Routine and frequent syphilis screening has the potential to ensure early detection and treatment, minimize disease burden, and help control the ongoing spread of syphilis and HIV. We aim to enhance syphilis screening among HIV-positive men by conducting a clinic-based intervention that incorporates opt-out syphilis testing into routine HIV laboratory evaluation for this population. Trial objectives are to determine the degree to which the intervention (1) increases the detection rate of untreated syphilis, (2) increases screening coverage, (3) increases screening frequency, and (4) reaches men at highest risk according to sexual behaviors.Methods/design: The trial is a pragmatic, stepped wedge cluster-randomized controlled trial that introduces the intervention stepwise across four urban HIV clinics in Ontario, Canada. The intervention includes standing orders for syphilis serological testing whenever a male in HIV care undergoes HIV viral load testing, which typically occurs every 3-6 months. The control condition is the maintenance of current, provider-initiated syphilis testing practice. Approximately 3100 HIV-positive men will be followed over 30 months. Test results will be obtained from the centralized provincial laboratory in Ontario and will be supplemented by a standardized clinical worksheet and medical chart review at the clinics. Detailed clinical, psychosocial, and behavioral data is available for a subset of men receiving HIV care who are also participants of the province-wide Ontario HIV Treatment Network Cohort Study. Process evaluation plans include audit and feedback of compliance of the participating centers to identify potential barriers to the introduction of this type of practice into routine care. Health economic components include evaluation of the impact and cost-effectiveness of the intervention.Discussion: This trial will be the first of its kind in Canada and will provide evidence regarding the feasibility, clinical effectiveness, and cost-effectiveness of a clinic-based intervention to improve syphilis screening among HIV-positive men. Involvement of knowledge users in all stages of trial design, conduct, and analysis will facilitate scale-up should the intervention be effective.Trial Registration: ClinicalTrials.gov NCT02019043. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
37. Comparison of coping strategies and supports between aboriginal and non-aboriginal people living with HIV in Ontario.
- Author
-
Jaworsky, Denise, Benoit, Anita, Raboud, Janet, O'Brien-Teengs, Doe, Blitz, Sandra, Rourke, Sean B, Burchell, Ann N, and Loutfy, Mona R
- Subjects
HIV infections & psychology ,INDIGENOUS peoples ,INTRAVENOUS drug abuse ,PSYCHOLOGICAL adaptation ,BIRTHPLACES ,CHI-squared test ,CONFIDENCE intervals ,EMPLOYMENT ,HIV-positive persons ,INCOME ,LONGITUDINAL method ,SCIENTIFIC observation ,QUESTIONNAIRES ,REGRESSION analysis ,RESEARCH funding ,PSYCHOLOGICAL stress ,SOCIAL support ,SOCIOECONOMIC factors ,EDUCATIONAL attainment ,CROSS-sectional method ,DESCRIPTIVE statistics ,MANN Whitney U Test - Abstract
Complex historical and cultural factors have contributed to the HIV epidemic among Aboriginal populations in Canada. This study assesses social supports, adaptive and maladaptive coping mechanisms, stress, and mastery of Canadian-born Aboriginal and Canadian-born Caucasian people living with HIV in Ontario and posits that coping and social support are important micro- and meso-level factors associated with the epidemic. This cross-sectional analysis included questionnaire data collected from 2007 to 2011 at HIV clinics in Toronto. Categorical and continuous variables were compared using chi-square and Wilcoxon rank sum tests, respectively. Correlates of social support and coping were determined using univariate and multivariable linear regression. The analysis included 70 Aboriginal and 665 Caucasian participants. Aboriginal participants had lower levels of employment, education, and annual household income. Aboriginal participants reported more overall (7 vs. 4,p = 0.0003), ongoing (4 vs. 2,p = 0.0004), and early childhood (2 vs. 1,p = 0.02) stressors. Maladaptive coping, adaptive coping, and mastery scores were similar between Aboriginal and Caucasian participants. In multivariable analysis, injection drug use and lower education levels were significant correlates of higher maladaptive coping and lower overall support scores. Despite numerous socioeconomic challenges and personal stressors, Aboriginal people living with HIV who are accessing care exhibited comparable coping and mastery scores to Canadian-born Caucasian people living with HIV, suggesting remarkable strengths within Aboriginal people living with HIV and their communities. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
38. Design and implementation of a sexual health intervention for migrant construction workers situated in Shanghai, China.
- Author
-
Mendelsohn, Joshua B., Calzavara, Liviana, Light, Lucia, Burchell, Ann N., Ren, Jinma, and Kang, Laiyi
- Abstract
Background: China's growing population of internal migrants has exceeded 236 million. Driven by rapid development and urbanization, this extreme population mobility creates opportunities for transmission of HIV and sexuallytransmitted infections (STI). Large numbers of rural migrants flock to megacities such as Shanghai in search of employment. Although migrants constitute a key population at heightened risk of acquiring HIV or an STI, there is a lack of easily accessible sexual health services available for them. In response, we designed a short, inexpensive sexual health intervention that sought to improve HIV and STI knowledge, while reducing stigma, risky sexual behaviour, and sexual transmission of HIV and STI among migrant construction workers (MCW) situated in Shanghai, China. Results: We implemented a three-armed, community-randomized trial spread across three administrative districts of Shanghai. The low-intensity intervention included educational pamphlets. The medium-intensity intervention included pamphlets, posters, and videos. The high-intensity intervention added group and individual counselling sessions. Across 18 construction sites, 1871 MCW were allocated at baseline to receive one intervention condition. Among baseline participants, 1304 workers were retained at 3-months, and 1013 workers were retained at 6-months, representing a total of 579 person-years of follow-up. All workers, regardless of participation, had access to informational materials even if they did not participate in the evaluation. Overall outputs included: 2284 pamphlets distributed, 720 posters displayed, 672 h of video shown, 376 participants accessed group counselling, and 61 participants attended individual counselling sessions. A multivariable analysis of participation found that men (aOR = 2.2; 95 % CI 1.1, 4.1; p = 0.036), workers situated in Huangpu district (aOR = 5.0; 95 % CI 2.6, 9.5; p < 0.001), and those with a middle school education (aOR = 1.9; 95 % CI 1.2, 3.0; p = 0.01) were more likely to have participated in intervention activities. Conclusion: A brief educational intervention that prioritized ease of delivery to a highly mobile workforce was feasible and easily accessed by participants. Routine implementation of sexual health interventions in workplaces that employ migrant labour have the potential to make important contributions toward improving HIV and STI outcomes among migrant workers in China's largest cities. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
39. Factors associated with the frequency of monitoring of liver enzymes, renal function and lipid laboratory markers among individuals initiating combination antiretroviral therapy: a cohort study.
- Author
-
Gillis, Jennifer, Bayoumi, Ahmed M., Burchell, Ann N., Cooper, Curtis, Klein, Marina B., Loutfy, Mona, Machouf, Nima, Montaner, Julio S. G., Tsoukas, Chris, Hogg, Robert S., Raboud, Janet, Montaner, Julio Sg, and Canadian Observational Cohort (CANOC) collaboration
- Subjects
ENZYME analysis ,INTRAVENOUS drug abuse ,HEPATITIS C ,HIV infections ,KIDNEY function tests ,LIPIDS ,LIVER ,LONGITUDINAL method ,RESEARCH funding ,HIGHLY active antiretroviral therapy ,ANTI-HIV agents ,MIXED infections ,DISEASE complications - Abstract
Background: As the average age of the HIV-positive population increases, there is increasing need to monitor patients for the development of comorbidities as well as for drug toxicities.Methods: We examined factors associated with the frequency of measurement of liver enzymes, renal function tests, and lipid levels among participants of the Canadian Observational Cohort (CANOC) collaboration which follows people who initiated HIV antiretroviral therapy in 2000 or later. We used zero-inflated negative binomial regression models to examine the associations of demographic and clinical characteristics with the rates of measurement during follow-up. Generalized estimating equations with a logit link were used to examine factors associated with gaps of 12 months or more between measurements.Results: Electronic laboratory data were available for 3940 of 7718 CANOC participants. The median duration of electronic follow-up was 3.5 years. The median (interquartile) rates of tests per year were 2.76 (1.60, 3.73), 2.55 (1.44, 3.38) and 1.42 (0.50, 2.52) for liver, renal and lipid parameters, respectively. In multivariable zero-inflated negative binomial regression models, individuals infected through injection drug use (IDU) were significantly less likely to have any measurements. Among participants with at least one measurement, rates of measurement of liver, renal and lipid tests were significantly lower for younger individuals and Aboriginal Peoples. Hepatitis C co-infected individuals with a history of IDU had lower rates of measurement and were at greater risk of having 12 month gaps between measurements.Conclusions: Hepatitis C co-infected participants infected through IDU were at increased risk of gaps in testing, despite publicly funded health care and increased risk of comorbid conditions. This should be taken into consideration in analyses examining factors associated with outcomes based on laboratory parameters. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
40. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada.
- Author
-
Patterson, Sophie, Cescon, Angela, Samji, Hasina, Keith Chan, Wendy Zhang, Raboud, Janet, Burchell, Ann N., Cooper, Curtis, Klein, Marina B., Rourke, Sean B., Loutfy, Mona R., Machouf, Nima, Montaner, Julio S. G., Tsoukas, Chris, and Hogg, Robert S.
- Subjects
LIFE expectancy ,ANTIRETROVIRAL agents ,DIAGNOSIS of HIV infections ,MEDICAL care of HIV-positive persons ,INTRAVENOUS injections ,PHYSIOLOGY - Abstract
Background: We sought to evaluate life expectancy and mortality of HIV-positive individuals initiating combination antiretroviral therapy (ART) across Canada, and to consider the potential error introduced by participant loss to follow-up (LTFU). Methods: Our study used data from the Canadian Observational Cohort (CANOC) collaboration, including HIV-positive individuals aged ≥18 years who initiated ART on or after January 1, 2000. The CANOC collaboration collates data from eight sites in British Columbia, Ontario, and Quebec. We computed abridged life-tables and remaining life expectancies at age 20 and compared outcomes by calendar period and patient characteristics at treatment initiation. To correct for potential underreporting of mortality due to participant LTFU, we conservatively estimated 30 % mortality among participants lost to follow-up. Results: 9997 individuals contributed 49,589 person-years and 830 deaths for a crude mortality rate of 16.7 [standard error (SE) 0.6] per 1000 person-years. When assigning death to 30 % of participants lost to follow-up, we estimated 1170 deaths and a mortality rate of 23.6 [SE 0.7] per 1000 person-years. The crude overall life expectancy at age 20 was 45.2 [SE 0.7] and 37.5 [SE 0.6] years after adjusting for LTFU. In the LTFU-adjusted analysis, lower life expectancy at age 20 was observed for women compared to men (32.4 [SE 1.1] vs. 39.2 [SE 0.7] years), for participants with injection drug use (IDU) history compared to those without IDU history (23.9 [SE 1.0] vs. 52.3 [SE 0.8] years), for participants reporting Aboriginal ancestry compared to those with no Aboriginal ancestry (17.7 [SE 1.5] vs. 51.2 [SE 1.0] years), and for participants with CD4 count <350 cells/μL compared to CD4 count ≥350 cells/μL at treatment initiation (36.3 [SE 0.7] vs. 43.5 [SE 1.3] years). Life expectancy at age 20 in the calendar period 2000-2003 was lower than in periods 2004-2007 and 2008-2012 in the LTFU-adjusted analyses (30.8 [SE 0.9] vs. 38.6 [SE 1.0] and 54.2 [SE 1.4]). Conclusions: Life expectancy and mortality for HIV-positive individuals receiving ART differ by calendar period and patient characteristics at treatment initiation. Failure to consider LTFU may result in underestimation of mortality rates and overestimation of life expectancy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
41. Colorectal cancer among persons with HIV: protocol for a systematic review and meta-analysis.
- Author
-
Djiometio Nguemo, Joseph, O'Neill, Tyler J., Kou, Nancy, Tynan, Anne-Marie, Agha, Ayda, Burchell, Ann N., and Antoniou, Tony
- Subjects
COLON cancer ,META-analysis ,QUANTITATIVE research ,PSYCHOMETRICS ,ONCOLOGY - Abstract
Background: As persons with HIV live longer, data regarding the epidemiology of colorectal cancer are required to optimize the long-term management of these patients. The purpose of this systematic review and meta-analysis is to synthesize evidence regarding the incidence of colorectal cancer in persons with HIV. Methods/design: Our primary outcome is the standardized incidence ratio of colorectal cancer among persons with HIV relative to rates in persons not living with HIV. Our secondary objectives are to summarize the evidence for differences with respect to stage at diagnosis, site of disease, and mortality due to colorectal cancer. We will search electronic bibliographic databases from their inception date, as well as conference proceedings and reference lists of included articles. Two investigators will independently screen citations and full-text articles, conduct data abstraction, and appraise study quality. We will examine clinical, methodological, and statistical heterogeneity among studies prior to conducting meta-analysis. Random effects meta-analysis methods will be employed to estimate standardized incidence ratios. These data will inform the development of guidelines for colorectal cancer screening in persons with HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
42. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care.
- Author
-
Cescon, Angela, Patterson, Sophie, Davey, Colin, Ding, Erin, Raboud, Janet M., Chan, Keith, Loutfy, Mona R., Cooper, Curtis, Burchell, Ann N., Palmer, Alexis K., Tsoukas, Christos, Machouf, Nima, Klein, Marina B., Rourke, Sean B., Rachlis, Anita, Hogg, Robert S., and Montaner, Julio S. G.
- Abstract
Introduction: Combination antiretroviral therapy (ART) significantly decreases morbidity, mortality and HIV transmission. We aimed to characterize the timing of ART initiation based on CD4 cell count from 2000 to 2012 and identify factors associated with late initiation of treatment. Methods: Participants from the Canadian Observational Cohort (CANOC), a multi-site cohort of HIV-positive adults initiating ART naively after 1 January 2000, in three Canadian provinces (British Columbia, Ontario and Que´bec) were included. Late initiation was defined as a CD4 count < 200 cells/mm
3 or an AIDS-defining illness before ART initiation (baseline). Temporal trends were assessed using the Cochran–Armitage test, and independent correlates of late initiation were identified using logistic regression. Results: In total, 8942 participants (18% female) of median age 40 years (Q1–Q3 33–47) were included. The median baseline CD4 count increased from 190 cells/mm3 (Q1–Q3 80–320) in 2000 to 360 cells/mm3 (Q1–Q3 220–490) in 2012 (p < 0.001). Overall, 4274 participants (48%) initiated ART with a CD4 count < 200 cells/mm3 or AIDS-defining illness. Late initiation was more common among women, non-MSM, older individuals, participants from Ontario and BC (vs. Québec), persons with injection drug use (IDU) history and individuals starting ART in earlier calendar years. In sub-analysis exploring recent (2008 to 2012) predictors using an updated CD4 criterion (< 350 cells/mm3 ), IDU and residence in BC (vs. Québec) were no longer significant correlates of late initiation. Conclusions: This analysis documents increasing baseline CD4 counts over time among Canadians initiating ART. However, CD4 counts at ART initiation remain below contemporary treatment guidelines, highlighting the need for strategies to improve earlier engagement in HIV care. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
43. Demographic and clinical factors correlating with high levels of psychological distress in HIV-positive women living in Ontario, Canada.
- Author
-
Benoit, Anita C., Light, Lucia, Burchell, Ann N., Gardner, Sandra, Rourke, Sean B., Wobeser, Wendy, and Loutfy, Mona R.
- Subjects
ANXIETY ,CONFIDENCE intervals ,STATISTICAL correlation ,MENTAL depression ,EPIDEMIOLOGY ,METROPOLITAN areas ,PROBABILITY theory ,RESEARCH funding ,RURAL conditions ,WOMEN'S health ,PSYCHOLOGY of women ,LOGISTIC regression analysis ,DATA analysis ,VIRAL load ,MULTIPLE regression analysis ,SOCIOECONOMIC factors ,HIV seroconversion ,DATA analysis software ,DESCRIPTIVE statistics ,CD4 lymphocyte count - Abstract
The concept of psychological distress includes a range of emotional states with symptoms of depression and anxiety and has yet to be reported in HIV-positive women living in Ontario, Canada, who are known to live with contributing factors. This study aimed to determine the prevalence, severity, and correlates of psychological distress among women accessing HIV care participating in the Ontario HIV Treatment Network Cohort Study using the Kessler Psychological Distress Scale (K10). The K10 is a 10-item, five-level response scale. K10 values range from 10 to 50 with values less than or equal to 19 categorized as not clinically significant, scores between 20 and 24 as moderate levels, 25–29 as high, and 30–50 as very high psychological distress. Correlates of psychological distress were assessed using the Pearson's chi-square test and univariate and multivariate logistic regression analysis. Moderate, high, and very high levels of psychological distress were experienced by 16.9, 10.4, and 15.1% of the 337 women in our cohort, respectively, with 57.6% reporting none. Psychological distress levels greater than 19, correlated with being unemployed (vs. employed/student/retired; AOR = 0.33, 95% CI: 0.13–0.83), living in a household without their child/children (AOR = 2.45, 95% CI: 1.33–4.52), CD4 counts < 200 cells/mm3(AOR = 2.07, 95% CI: 0.89–4.80), and to a lesser degree an education of some college or less (vs. completed college or higher; AOR=1.71, 95% CI: 0.99–2.95). Age and ethnicity, a priori variables of interest, did not correlate with psychological distress. Findings suggest that socioeconomic factors which shape the demography of women living with HIV in Ontario, low CD4 counts, and losing the opportunity to care for their child/children has a significant relationship with psychological distress. Approaches to manage psychological distress should address and make considerations for the lived experiences of women since they can act as potential barriers to improving psychological well-being. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
44. Factors Associated with Late Initiation of Highly Active Antiretroviral Therapy among Young HIV-Positive Men and Women Aged 18 to 29 Years in Canada.
- Author
-
Palmer, Alexis K., Cescon, Angela, Chan, Keith, Cooper, Curtis, Raboud, Janet M., Miller, Caroline L., Burchell, Ann N., Klein, Marina B., Machouf, Nima, Montaner, Julio S. G., Tsoukas, Chris, Hogg, Robert S., and Loutfy, Mona R.
- Published
- 2014
- Full Text
- View/download PDF
45. Gender Differences in Clinical Outcomes among HIV-Positive Individuals on Antiretroviral Therapy in Canada: A Multisite Cohort Study.
- Author
-
Cescon, Angela, Patterson, Sophie, Chan, Keith, Palmer, Alexis K., Margolese, Shari, Burchell, Ann N., Cooper, Curtis, Klein, Marina B., Machouf, Nima, Montaner, Julio S. G., Tsoukas, Chris, Hogg, Robert S., Raboud, Janet M., and Loutfy, Mona R.
- Subjects
SEX differences (Biology) ,COHORT analysis ,HIV-positive persons ,PHARMACOEPIDEMIOLOGY ,POPULATION biology ,EPIDEMIOLOGY - Abstract
Background: Cohort data examining differences by gender in clinical responses to combination antiretroviral therapy (ART) remain inconsistent and have yet to be explored in a multi-province Canadian setting. This study investigates gender differences by injection drug use (IDU) history in virologic responses to ART and mortality. Methods: Data from the Canadian Observational Cohort (CANOC) collaboration, a multisite cohort study of HIV-positive individuals initiating ART after January 1, 2000, were included. This analysis was restricted to participants with a follow-up HIV-RNA plasma viral load measure and known IDU history. Weibull hazard regression evaluated time to virologic suppression (2 consecutive measures <50 copies/mL), rebound (>1000 copies/mL after suppression), and all-cause mortality. Sensitivity analyses explored the impact of presumed ART use in pregnancy on virologic outcomes. Results: At baseline, women (1120 of 5442 participants) were younger (median 36 vs. 41 years) and more frequently reported IDU history (43.5% vs. 28.8%) (both p<0.001). Irrespective of IDU history, in adjusted multivariable analyses women were significantly less likely to virologically suppress after ART initiation and were at increased risk of viral load rebound. In adjusted time to death analysis, no differences by gender were noted. After adjusting for presumed ART use in pregnancy, observed gender differences in time to virologic suppression for non-IDU, and time to virologic rebound for IDU, became insignificant. Conclusions: HIV-positive women in CANOC are at heightened risk for poor clinical outcomes. Further understanding of the intersections between gender and other factors augmenting risk is needed to maximize the benefits of ART. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
46. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada.
- Author
-
Samji, Hasina, Cescon, Angela, Hogg, Robert S., Modur, Sharada P., Althoff, Keri N., Buchacz, Kate, Burchell, Ann N., Cohen, Mardge, Gebo, Kelly A., Gill, M. John, Justice, Amy, Kirk, Gregory, Klein, Marina B., Korthuis, P. Todd, Martin, Jeff, Napravnik, Sonia, Rourke, Sean B., Sterling, Timothy R., Silverberg, Michael J., and Deeks, Stephen
- Subjects
LIFE expectancy ,HIV-positive persons ,ANTIRETROVIRAL agents ,DRUG therapy ,VIRAL disease treatment - Abstract
Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000–2007 in the U.S. and Canada. Methods: Participants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged ≥20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables. Results: The crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000–2002 to 2006–2007. Men and women had comparable life expectancies in all periods except the last (2006–2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts <350 cells/mm
3 . Conclusions: A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population. Differences by sex, race, HIV transmission risk group, and CD4 count remain. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
47. Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study.
- Author
-
Raboud, Janet, DeSheng Su, Burchell, Ann N., Gardner, Sandra, Walmsley, Sharon, Bayoumi, Ahmed M., Blitz, Sandra, Cooper, Curtis, Salit, Irving, Cohen, Jeff, Rourke, Sean B., and Loutfy, Mona R.
- Subjects
HIV infections ,THERAPEUTICS ,EPIDEMIOLOGY ,COHORT analysis ,GENERALIZABILITY theory ,COMPARATIVE studies ,REGRESSION analysis ,VIRAL load - Abstract
Background: Participation bias is a well-known phenomenon in epidemiologic research, where individuals consenting to research studies differ from individuals who are not able or willing to participate. These dissimilarities may limit the generalizability of results of research studies. Quantification of the participation bias is essential for the interpretation of research findings. Methods: The Ontario HIV Treatment Network Cohort Study (OCS) is an ongoing open cohort study of HIV positive individuals receiving care at one of 11 sites in Ontario. OCS participants from 4 sites were compared to nonparticipants (those who declined or were not approached) at those sites with regard to gender, age, HIV risk factor, CD4 count and viral load (VL). Generalized logit regression models were used to identify predictors of declining to participate or not being approached to participate. Results: Compared to participants (P) in the OCS, individuals who declined to participate (D) and those who were not approached (NA) were slightly younger (D:45, NA:44 vs P:46), less likely to be male (D: 71%, NA:75% vs P:88%), less likely to be Caucasian (D:41%, NA:57% vs P:72%) and less likely to be Canadian-born (D: 39%, NA: 52% vs P: 69%). Patients who were not approached to participate were less likely to have VL < 50 copies/mL than other patients (D: 75%, NA: 62%, P: 74%) and had lower CD4 counts than OCS participants (D: 450 cells/mm³, NA: 420 cells/mm³, P: 480 cells/mm³). Conclusions: Significant demographic and clinical differences were found between OCS participants and non-participants. Extrapolation of research findings to other populations should be undertaken cautiously. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
48. Characterization of an Emerging Heterosexual HIV Epidemic in Russia.
- Author
-
Burchell, Ann N., Calzavara, Liviana M., Orekhovsky, Victoria, and Ladnaya, Natalia N.
- Subjects
- *
SEXUALLY transmitted disease risk factors , *COMMUNICABLE diseases , *EPIDEMICS , *HIV , *HIV infections , *HIV-positive women , *HIV-positive men , *UNSAFE sex , *SEXUAL intercourse , *DISEASE risk factors - Abstract
The article presents a case-control study to determine sexual risk factors for heterosexually-acquired HIV infections in the Russian Federation. The study involving 166 participants was conducted in the regions of Altaiskiy Krai, Krasnoyarskiy Krai, Saratov Oblast, and Tverskaya Oblast. It was found that risk factors for heterosexually-acquired HIV infections included unprotected sex with an HIV-positive regular partner, a regular sexual partner who was an injection drug user, five or more sexual partners, unprotected sex with a partner who had a diagnosed sexually transmitted infection (STI) or signs/symptoms of an STI, and undiagnosed signs/symptoms of an STI.
- Published
- 2008
- Full Text
- View/download PDF
49. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities.
- Author
-
Calzavara, Liviana, Ramuscak, Nancy, Burchell, Ann N., Swantee, Carol, Myers, Ted, Ford, Peter, Fearon, Margaret, and Raymond, Sue
- Subjects
HIV infections ,HEPATITIS C ,PRISONERS ,HIV ,HEPATITIS C virus ,DISEASES - Abstract
Background: Each year more than 56 000 adult and young offenders are admitted to Ontario's remand facilities (jails, detention centres and youth centres). The prevalence of HIV infection in Ontario remand facilities was last measured over a decade ago, and no research on the prevalence of hepatitis C virus (HCV) infection has been conducted in such facilities. We sought to determine the prevalence of HIV infection, HCV infection and HIV-HCV coinfection among inmates in Ontario's remand facilities. Methods: A voluntary and anonymous cross-sectional prevalence study of HIV and HCV infections was conducted among people admitted to 13 selected remand facilities across Ontario between Feb. 1, 2003, and June 20, 2004. Data collection included a saliva specimen for HIV and HCV antibody screening and an interviewer-administered survey. Prevalence rates and 95% confidence intervals were calculated and examined according to demographic characteristics, region of incarceration and self-reported history of injection drug use. Results: In total, 1877 participants provided both a saliva specimen and survey information. Among the adult participants, the prevalence of HIV infection was 2.1% among men and 1.8% among women. Adult offenders most likely to have HIV infection were older offenders (30 years) and injection drug users. The prevalence of HCV infection was 15.9% among men, 30.2% among women and 54.7% among injection drug users. Adult offenders most likely to have HCV infection were women, older offenders (≥30 years) and injection drug users. The prevalence of HCV-HIV coinfection was 1.2% among men and 1.5% among women. It was highest among older inmates and injection drug users. Among the young offenders, none was HIV positive and 1 (0.4%) was HCV positive. On the basis of the study results, we estimated that 1079 HIV-positive adults and 9208 HCV-positive adults were admitted to remand facilities in Ontario from Apr. 1, 2003, to Mar. 31, 2004. Interpretation: Adult offenders entering Ontario remand facilities have a considerably higher prevalence of HIV and HCV infections than the general population. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
50. Delayed Application of Condoms Is a Risk Factor for Human Immunodeficiency Virus Infection among Homosexual and Bisexual Men.
- Author
-
Calzavara, Liviana, Burchell, Ann N., Remis, Robert S., Major, Carol, Corey, Paul, Myers, Ted, Millson, Margaret, and Wallace, Evelyn
- Subjects
HIV ,GAY men ,BISEXUAL men ,DISEASE risk factors ,UNSAFE sex ,CONDOMS ,DISEASES - Abstract
The objective of this analysis was to identify risk factors for recent human immunodeficiency virus (HIV) infection among homosexual and bisexual men in Ontario, Canada, during 1998–2001. Participants were recruited through the provincial HIV diagnostic laboratory and through physicians and community organizations. HIV test results were used to identify recent seroconverters (cases). A subsample of 183 men (62 cases and 121 controls) enrolled in the Polaris HIV Seroconversion Study as of June 2001 was analyzed. This analysis focused on sexual behaviors with partners who were HIV-positive or whose HIV status was unknown. In multiple logistic regression, independent risk factors were identified. Rates of unprotected receptive oral, insertive anal, and receptive anal sex and delayed application of condoms during receptive anal sex (RAS) were significantly higher among cases (97%, 41%, 53%, and 32%, respectively) than among controls (73%, 19%, 14%, and 2%). Independent risk factors for HIV infection were RAS without condoms (odds ratio = 4.4, p = 0.0004) and delayed application of condoms during RAS (odds ratio = 5.8, p = 0.01). There was an association with condom failure (breakage or slippage) during RAS that approached significance (odds ratio = 2.9, p = 0.09). Delayed application of condoms for RAS may result in contact with preejaculatory fluid. This behavior, which to date has received little attention, may pose as much risk for HIV infection as fully unprotected RAS. [ABSTRACT FROM PUBLISHER]
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.